Published in Vaccine Weekly, March 2nd, 2011
Ms. Powers will provide a corporate and clinical update, including an update on NWBT's DCVax® therapeutic cancer vaccine for Glioblastoma multiforme, which is in a Phase II, randomized, double blinded, placebo controlled clinical trial. The update will include the striking long-term follow-up...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly